USF-LVHN SELECT
Anti-CD80/86 antibodies inhibit inflammatory reaction and improve graft survival in a high-risk murine corneal transplantation rejection model.
Publication/Presentation Date
3-22-2022
Abstract
We investigated the effects of anti-CD80/86 antibodies in a murine high-risk corneal transplantation rejection model. A mixed lymphocyte reaction (MLR) assay was conducted with anti-CD80/86 antibodies. Inflammatory cytokine levels in the culture supernatant were measured using an enzyme-linked immunosorbent assay. Interferon (IFN)-γ-producing CD4
Volume
12
Issue
1
First Page
4853
Last Page
4853
ISSN
2045-2322
Published In/Presented At
Zhu, J., Inomata, T., Nakamura, M., Fujimoto, K., Akasaki, Y., Fujio, K., Yanagawa, A., Uchida, K., Sung, J., Negishi, N., Nagino, K., Okumura, Y., Miura, M., Shokirova, H., Kuwahara, M., Hirosawa, K., Midorikawa-Inomata, A., Eguchi, A., Huang, T., Yagita, H., … Murakami, A. (2022). Anti-CD80/86 antibodies inhibit inflammatory reaction and improve graft survival in a high-risk murine corneal transplantation rejection model. Scientific reports, 12(1), 4853. https://doi.org/10.1038/s41598-022-08949-9
Disciplines
Medical Education | Medicine and Health Sciences
PubMedID
35318419
Department(s)
USF-LVHN SELECT Program, USF-LVHN SELECT Program Students
Document Type
Article